Professional Documents
Culture Documents
A. Renal Size
B. Hydronephrosis
C. Cortical thickness
D. Urinary sediment
A. Diabetes
B. Amyloidosis
C. Minimal Change Disease
D. All of the above
A. 5-15%
B. 25-35%
C. 55-75%
D. 45-55%
A. Oral frusemide
B. Demeclocycline
C. Oral urea
D. All of the above
• Demeclocycline
• Oral Urea
A. Atleast 10%
B. Atleast 20%
C. Atleast 50%
D. None of these
A. 150 ml/hr
B. 250 ml/hr
C. 350 ml/hr
D. 450 ml/hr
asystole
A. Glucocorticoids
B. Gallium nitrate
C. IV phosphate
D. Ketoconazole
• Volume Expansion
• Loop Diuretics
• Bisphosphonates
• Gallium Nitrate
• Denosumab
• Hemodialysis
• Glucocorticoids
© Medi - Lectures Dr Shubham Upadhyay 31
12. Which of the following indicate metabolic acidosis - metabolic
acidosis?
A. Cyclosporine
B. Congestive Heart Failure
C. Amphotericin B
D. Liver Failure
A. >20 mm Hg
B. >30 mm Hg
C. >40 mm Hg
D. >50 mm Hg
A. 70 ml/min/1.73 m2
B. 80 ml/min/1.73 m2
C. 90 ml/min/1.73 m2
D. 60 ml/min/1.73 m2
A. 90 mL/min/1.73 m2
B. 60 mL/min/1.73 m2
C. 30 mL/min/1.73 m2
D. 45 mL/min/1.73 m2
• Bledding Diathesis
• ↓ RBC survival
• Hemodialysis
• ↑ PTH
A. Calcium carbonate
B. Calcium acetate
C. Lanthanum
D. None of the above
A. Protamine
B. Desmopressin
C. N Acetylcysteine
D. IV calcium
A. Polytetrafluoroethylene (PTFE)
B. Polyethylene (PE)
C. Polyvinylidene fluoride (PVDF)
D. Polytrifluoroethylene
• Arteriovenous Graft
• Vascular Catheter
• Weight Gain
• Hyperglycemia
• Metabolic Disturbances
A. Brought in dead
B. Unsuccessful resuscitation
C. Cardiac arrest in a hospital
D. Cardiac arrest after brainstem death
A. Cyclosporine
B. Alemtuzumab
C. Everolimus
D. Belatacept
HALLMARK
PROTEINURIA
s. ALBUMIN
HYPERTENSION
CAST
© Medi - Lectures Dr Shubham Upadhyay 70
NEPHRITIC SYNDROME
ANTIBODY IMMUNE COMPLEX PAUCI IMMUNE
MEDIATED
GRANULAR PATTERN
LINEAR DEPOSITS ON
GBM NO DEPOSITS
GOOD PASTEUR • WEGENER’S
SYNDROME GRANULOMATOSIS
• MICROSCOPIC
POLYANGITIS
• STEROIDS- NO ROLE
HEMATURIA +
OLIGURIA
A. Female preponderance
B. Peak incidence in II & III decades of life
C. Recurrent episodes of macroscopic hematuria
D. Between episodes, urinalysis is normal
A. 3
B. 4
C. 5
D. 6
A. Hepatitis C
B. Malignancy
C. Nonsteroidal anti-inflammatory drug use
D. Tuberculosis
• MAHA + • MAHA +
© Medi - Lectures Dr Shubham Upadhyay 85
HUS vs TTP
FEATURE HUS TTP
INVESTIGATIO • PT/aPTT : Normal
NS • Coomb’s Test : Negative
TREATMENT • Mainstay: Supportive (Fluid & • Mainstay: Plasmapheresis
Electrolyte balance)
A. Caplacizumab
B. Eculizumab
C. Ravuliumab
D. Rituximab
A. POEMS syndrome
B. HELLP syndrome
C. aHUS
D. cTTP
ADTKD
A. Absence of Proteinuria
B. Mutation in gene encoding Tamm-Horsfall protein.
C. Benign urine sediments
D. Decreased uric acid levels
A. Aristolochic Acid
B. Hyperuricemia
C. Nephrogenic DI
D. Nephrocalcinosis
A. Hypercalcemia
B. Hyperuricemia
C. Hyperoxaluria
D. Hyperkalemia
A. Na+
B. K+
C. Cl
D. HCO3-
LIDDLE’S SYNDROME:
• Na+ gain -> Water gain -> ↑ BP
• Renin ↓ -> Aldosterone ↓
• K+ excre on ↑ -> Hypokalemia
• H+ excretion -> Metabolic alkalosis
• Treatment: Amiloride
© Medi - Lectures Dr Shubham Upadhyay 111
50. Which of the following is not a finding in renal tubular defects?
A. Renal calcification
B. Electrolyte disorders
C. Hypoalbuminemia
D. Large Kidneys